MedTech Dive December 18, 2023
Elise Reuter

The sale to H.I.G. Capital will leave Zimvie focused on its dental business and help reduce its debt.

Dive Brief:

  • Zimvie announced plans on Monday to sell its spine business to Miami-based investment firm H.I.G. Capital, narrowing the company’s focus to its dental business.
  • H.I.G. will pay $315 million in cash and a $60 million promissory note that will accrue interest at a rate of 10% per year, for a total consideration of $375 million.
  • The sale is “a step in the right direction for ZimVie as it allows it to double down on what we view as the more attractive of its two end markets while also significantly improving its financial position,” J.P. Morgan analyst Robbie...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article